At a glance
Key figures (IFRS) |
|||||
|
|
|
|
||
(thousands of €, if not stated otherwise) |
31/12/2017 |
31/12/2016 |
31/12/2015 |
||
|
|||||
Income Statement |
|
|
|
||
Revenues |
127,087 |
129,519 |
39,563 |
||
Other income |
28,830 |
22,093 |
21,017 |
||
R&D expenditure |
(218,502) |
(139,573) |
(129,714) |
||
S, G&A expenses |
(27,218) |
(23,530) |
(20,308) |
||
Operating expenses |
(245,720) |
(163,103) |
(150,023) |
||
Operating loss |
(89,802) |
(11,491) |
(89,444) |
||
Net financial results |
(25,705) |
65,737 |
(30,184) |
||
Taxes |
(198) |
(235) |
1,218 |
||
Net income / loss (–) |
(115,704) |
54,012 |
(118,410) |
||
|
|
|
|
||
Balance sheet |
|
|
|
||
Cash, cash equivalents and restricted cash |
1,152,369 |
980,909 |
348,216 |
||
R&D incentives receivables |
75,783 |
64,342 |
58,545 |
||
Assets |
1,286,274 |
1,083,338 |
442,514 |
||
Shareholders' equity |
1,011,983 |
758,701 |
364,999 |
||
Deferred income |
219,892 |
285,612 |
39,806 |
||
Other liabilities |
54,399 |
39,025 |
37,709 |
||
|
|
|
|
||
Cash flow |
|
|
|
||
Operational cash burn (–) / operational cash flow(1) |
(154,089) |
231,881 |
(121,145) |
||
Cash flow from financing activities |
353,357 |
395,996 |
271,370 |
||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(27,808) |
4,816 |
118 |
||
Increase in cash, cash equivalent and restricted cash |
171,460 |
632,693 |
150,343 |
||
Cash, cash equivalents and restricted cash on 31 December |
1,152,369 |
980,909 |
348,216 |
||
|
|
|
|
||
Financial ratios |
|
|
|
||
Number of shares issued on 31 December |
50,936,778 |
46,256,078 |
39,076,342 |
||
Basic income / loss (–) per share (in €) |
(2.34) |
1.18 |
(3.32) |
||
Diluted income / loss (–) per share (in €) |
(2.34) |
1.14 |
(3.32) |
||
Share price on 31 December (in €) |
78.98 |
60.94 |
56.76 |
||
Total group employees on 31 December (number) |
600 |
508 |
435 |